Tumor tissues might undergo a further decrease in the expression level of ACE2 after SARS-CoV-2 infection, which could produce further deterioration of immune infiltration and worsen the prognosis of luminal B breast cancer after SARS-CoV-2 infection. Here, ACE2 is linked to breast carcinoma.